Trial NCT03854227

View at ClinicalTrials.gov 
Org. Study IDs: C3851001

Last trial update was posted on 2022-11-22

MeSH Interventions

Docetaxel

MeSH Conditions

Neoplasms

Other Conditions

Advanced Solid Tumors Metastatic Solid Tumors

Stopping Reasons

The study has been terminated based on a strategic evaluation within the current Pfizer oncology portfolio. This decision is not due to any safety concerns or requests from any regulatory authorities.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID